Delivery Order SPE2DR25D2007-SPE2DR26FM31E
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 26, 2025, for the supply of Nucynta ER 50 mg tablets (60-count units) with a contract value of $1,990.55. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The contract is set for ultimate completion by September 29, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,156.26 by the Defense Logistics Agency (DLA) on December 11, 2025, for the supply of Nucynta ER 50 mg tablets (60-count packages). The contract carries a firm fixed price structure with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. Performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania, with delivery required by December 12,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,658.73 for Nucynta Tabs 50mg on November 6, 2025, with completion scheduled for November 7, 2025. This competitively awarded, firm fixed-price contract serves the Department of Defense's Medical Supply Chain and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction under a larger contract vehicle, reflecting the company's role as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) with a ceiling value of $1,425.14. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is set to be completed by November 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on November 25, 2025, for the supply of Nucynta ER Tablets 100mg with a ceiling value of $12,560.28. The competitively awarded, firm fixed-price delivery order is funded by the Defense Department's Medical Supply Chain and is due for completion by November 26, 2025. This award represents a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Nucynta ER 200 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $2,761.93. This non-set-aside delivery order represents a competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 22, 2025. The order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) valued at $2,650.80. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set to complete by October 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $12,642.22 for Nucynta Tabs 75mg, a pain management pharmaceutical, by the Defense Logistics Agency's Medical Supply Chain on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and specifies performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,137.68 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count units) under a firm fixed-price contract. The award, issued on November 24, 2025, with an ultimate completion date of November 25, 2025, represents a competitive procurement with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 8, 2025, for 60 tablets of Nucynta ER 200 mg. This firm fixed-price, competitively awarded contract carries a ceiling value of $2,411.52 and is scheduled for completion by September 9, 2025. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DR25D2007Indefinite Delivery Contract
- SPE2DR25D2007-SPE2DR26FM31EDelivery Order
AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on December 29, 2025, for the supply of Nucynta ER 150 mg tablets (60-count packages) with a contract value of $5,939.01. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The ultimate completion date is December 30, 2025, with performance to occur at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. Through this vehicle, AmerisourceBergen serves critical customers including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards anticipated, positioning AmerisourceBergen as a key supplier within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 12/28/25 |